Don C. Des Jarlais

147.5k total citations · 2 hit papers
525 papers, 21.6k citations indexed

About

Don C. Des Jarlais is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Don C. Des Jarlais has authored 525 papers receiving a total of 21.6k indexed citations (citations by other indexed papers that have themselves been cited), including 460 papers in Epidemiology, 305 papers in Infectious Diseases and 114 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Don C. Des Jarlais's work include HIV, Drug Use, Sexual Risk (424 papers), HIV/AIDS Research and Interventions (290 papers) and Opioid Use Disorder Treatment (108 papers). Don C. Des Jarlais is often cited by papers focused on HIV, Drug Use, Sexual Risk (424 papers), HIV/AIDS Research and Interventions (290 papers) and Opioid Use Disorder Treatment (108 papers). Don C. Des Jarlais collaborates with scholars based in United States, Vietnam and France. Don C. Des Jarlais's co-authors include Samuel R. Friedman, Holly Hagan, Nicole Crepaz, Cynthia M. Lyles, Kamyar Arasteh, Alan Neaigus, Theresa E. Perlis, Denise Paone, Courtney McKnight and Jonathan Feelemyer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Don C. Des Jarlais

511 papers receiving 20.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement

2004 1.7k citations Don C. Des Jarlais et al. profile →
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

2011 963 citations Holly Hagan, Don C. Des Jarlais et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Don C. Des Jarlais United States	73	16.1k	9.8k	5.2k	5.0k	4.0k	525	21.6k
Mark Tyndall Canada	74	12.6k 0.8×	6.5k 0.7×	3.0k 0.6×	5.3k 1.1×	2.4k 0.6×	263	16.2k
Samuel R. Friedman United States	72	14.0k 0.9×	9.6k 1.0×	6.1k 1.2×	4.1k 0.8×	1.6k 0.4×	466	18.5k
Frederick L. Altice United States	60	10.4k 0.6×	9.4k 1.0×	3.5k 0.7×	3.3k 0.7×	1.2k 0.3×	463	15.5k
Steffanie A. Strathdee United States	91	26.2k 1.6×	17.0k 1.7×	6.8k 1.3×	6.4k 1.3×	5.0k 1.2×	773	34.7k
Julio Montaner Canada	87	20.7k 1.3×	20.9k 2.1×	5.5k 1.1×	5.7k 1.1×	4.3k 1.1×	755	35.8k
Tim Rhodes United Kingdom	60	10.3k 0.6×	5.8k 0.6×	3.2k 0.6×	3.1k 0.6×	1.8k 0.5×	264	13.2k
Evan Wood Canada	85	20.6k 1.3×	12.0k 1.2×	6.4k 1.2×	11.3k 2.2×	1.3k 0.3×	694	28.6k
Matthew Hickman United Kingdom	83	19.3k 1.2×	5.9k 0.6×	3.7k 0.7×	8.0k 1.6×	6.9k 1.7×	620	28.2k
Martin T. Schechter Canada	67	8.5k 0.5×	5.8k 0.6×	2.6k 0.5×	4.3k 0.8×	925 0.2×	373	15.8k
Carl A. Latkin United States	74	11.1k 0.7×	8.5k 0.9×	7.6k 1.4×	3.7k 0.7×	965 0.2×	835	23.3k

Countries citing papers authored by Don C. Des Jarlais

Since Specialization

Citations

This map shows the geographic impact of Don C. Des Jarlais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don C. Des Jarlais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don C. Des Jarlais more than expected).

Fields of papers citing papers by Don C. Des Jarlais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don C. Des Jarlais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don C. Des Jarlais. The network helps show where Don C. Des Jarlais may publish in the future.

Co-authorship network of co-authors of Don C. Des Jarlais

This figure shows the co-authorship network connecting the top 25 collaborators of Don C. Des Jarlais. A scholar is included among the top collaborators of Don C. Des Jarlais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don C. Des Jarlais. Don C. Des Jarlais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uusküla, Anneli, Jonathan Feelemyer, & Don C. Des Jarlais. (2023). HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review. European Journal of Public Health. 33(3). 381–388. 10 indexed citations

Nagot, Nicolas, Vinh Vu Hai, Delphine Rapoud, et al.. (2021). Alarming Tuberculosis Rate Among People Who Inject Drugs in Vietnam. Open Forum Infectious Diseases. 9(2). ofab548–ofab548. 6 indexed citations

Grivel, Margaux M., et al.. (2021). Sociodemographic and behavioral factors associated with COVID-19 stigmatizing attitudes in the U.S.. Stigma and Health. 6(4). 371–379. 5 indexed citations

Meltzer, Gabriella, et al.. (2021). Behavioral Correlates of COVID-19 Worry: Stigma, Knowledge, and News Source. International Journal of Environmental Research and Public Health. 18(21). 11436–11436. 12 indexed citations

Rapoud, Delphine, Catherine Quillet, Phạm Minh Khuê, et al.. (2020). Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C). BMJ Open. 10(11). e039234–e039234. 8 indexed citations

Linton, Sabriya L., Hannah L. F. Cooper, Mary E. Kelley, et al.. (2017). Cross-sectional association between ZIP code-level gentrification and homelessness among a large community-based sample of people who inject drugs in 19 US cities. BMJ Open. 7(6). e013823–e013823. 26 indexed citations

Jarlais, Don C. Des, Kamyar Arasteh, Jonathan Feelemyer, et al.. (2017). Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS and Behavior. 22(7). 2161–2171. 13 indexed citations

Huik, Kristi, Silver Türk, Don C. Des Jarlais, et al.. (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral Immunology. 29(8). 464–470. 7 indexed citations

Elliott, Jennifer C., Deborah S. Hasin, & Don C. Des Jarlais. (2016). Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV). Addictive Behaviors. 63. 57–62. 5 indexed citations

10.

Uusküla, Anneli, Kristiina Rajaleid, Ave Talu, Katri Abel‐Ollo, & Don C. Des Jarlais. (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal of Drug Policy. 24(4). 312–318. 20 indexed citations

11.

Jarlais, Don C. Des, Kamyar Arasteh, Courtney McKnight, et al.. (2013). HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection. PLoS ONE. 8(6). e66874–e66874. 10 indexed citations

12.

Talal, Andrew H., Rositsa B. Dimova, Randy Seewald, et al.. (2012). Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. Journal of Substance Abuse Treatment. 44(1). 115–119. 8 indexed citations

13.

Jarlais, Don C. Des, et al.. (2010). Syringe exchange programs - United States, 2008.. MMWR Morbidity and Mortality Weekly Report. 59(45). 1488–1491. 48 indexed citations

14.

Vorobjov, Sigrid, Anneli Uusküla, Katri Abel‐Ollo, Ave Talu, & Don C. Des Jarlais. (2009). Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia. Journal of Urban Health. 86(6). 918–928. 11 indexed citations

15.

Strauss, Shiela M., Corrine Munoz‐Plaza, Don C. Des Jarlais, et al.. (2007). Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Services Research. 7(1). 39–39. 41 indexed citations

16.

Deren, Sherry, Marjorie F. Goldstein, Don C. Des Jarlais, et al.. (2001). Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment. Journal of Substance Abuse Treatment. 20(2). 185–189. 15 indexed citations

17.

Deren, Sherry, et al.. (1996). HIV Risk Behaviors Among Dominican Brothel and Street Prostitutes in New York City. AIDS Education and Prevention. 8(5). 444–456. 25 indexed citations

18.

Jarlais, Don C. Des. (1992). The first and second decades of AIDS among injecting drug users. British Journal of Addiction. 87(3). 347–353. 65 indexed citations

19.

Jarlais, Don C. Des & Jo L. Sotheran. (1990). The public health paradigm for AIDS and drug use: Shifting the time frame. Addiction. 85(3). 348–350. 4 indexed citations

20.

Jarlais, Don C. Des, et al.. (1990). Letters to the Editor. Aids Patient Care. 4(6). 2–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact